April 19, 20244Law firm Cleary Gottlieb making profitable strides with standalone AI/tech unit ClearyX
June 21, 20234Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture
June 19, 20234The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.
April 17, 20244Fieldfisher Expands Media, Digital Commerce and IP Litigation Practice Areas in Germany
Homepage North America North America Legal Chronicle Alexion Pharmaceuticals’ $930 Million Acquisition of Achillion Pharmaceuticals Alexion Pharmaceuticals’ $930 Million Acquisition of Achillion Pharmaceuticals October 17, 2019 Ambrogio Visconti Foley Hoag LLP assisted Alexion Pharmaceuticals Inc in the transaction. Alexion Pharmaceuticals (NASDAQ:ALXN) executed the acquisition of biotech Achillion Pharmaceuticals Inc (NASDAQ:ACHN). The initial consideration of… This content is for Standard 1 Year members only.Login Join Now